- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03157609
Can the SpotOn™ Zero-Heat-Flux-Thermometry Sensor Accurately Measure Core Temperature in Children?
Paediatric Thermometry: Can the SpotOn™ Zero-Heat-Flux-Thermometry Sensor Accurately Measure Core Temperature in Children?
Study Overview
Status
Intervention / Treatment
Detailed Description
Temperature regulation in the perioperative period is of primordial importance in paediatric population - a particularly sensitive group for thermal variations.
In fact, infants lose a significantly high percentage of their core heat from skin perspiration in comparison to adults (where it approximates roughly 10%). This percentage can go up to 20% in premature infants and relates to the fact that cutaneous heat loss is "grosso modo" proportional to body surface area.
This higher thermal vulnerability is aggravated during the perioperative period, where body exposure to the cold operating room environment is increased, and where anaesthetic interventions impair the compensatory mechanisms to the extent of being unable to sufficiently increase heat production to compensate for hypothermia.
An alternative thermometry method called Zero-heat-flux was developed in the 1970's in an attempt to compensate for the limitations of pure skin temperature, while maintaining its practical character. It is based on the principle that the temperature 1-2 cm below skin surface reasonably approximates core temperature. In order to measure it, it uses 4-layered probe, with the following inside-out structure: patient temperature thermistor, insulating foam layer, heating (flex) circuit, and insulating foam. A servo-controlled system actively warms the probe circuit to the point where, theoretically, temperature equilibrium is achieved between the skin and deeper structures and there is zero heat transfer to the surrounding areas. This concept is commonly exemplified as the creation of a vertical isothermal tunnel between the skin surface and lower dermal layers. Assuming a good tissue perfusion, dermal temperature will reasonably approximate core temperature.
Although a systematic adult population validation is on its way, no data on the paediatric patients exists.
Considering the practical and non-invasive character of this skin surface probe, as well as the abovementioned thermal sensitivity concerns on the paediatric population, it seems that, should the probe indeed prove to be accurate in this age range, it can definitely contribute to the improvement of the perioperative temperature management in children.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vlaams-Brabant
-
Jette, Vlaams-Brabant, Belgium, 1090
- Universitair Ziekenhuis Brussel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA I & II
- Age: 1d - 16 years
- Elective surgery
- Minimum anaesthesia time of 30 minutes
Exclusion Criteria:
- Fragile skin state in the forehead
- Know allergy to probe adhesive
- Maxillofacial trauma or lesions
- Procedures impeding proper use of SpotOn™ sensor (mostly maxillo-facial)
- Abnormal oesophageal anatomy/gastroesophageal procedures.
- Coagulopathy
- Neurologically impaired children with abnormal thermoregulation
- Extensive Haemodynamic instability
- Need for Vasopression
- Procedures associated with extended use of rinsing fluids (abdominal/thoracic lavages)
- Thoracoscopic/thoracotomic procedures (oesophageal probe cooling)
- Need for use of "over body" forced air warming systems
- Malignant Hyperthermia or family history of malignant hyperthermia
- Fever / Infectious patient
- All conditions that might be judged to alter skin perfusion in an abnormal way
- Anatomical variants (overt hydrocephalus …)
- Calibration/device failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thermometry with SpotOn
Application of SpotOn sensor on forehead.
|
Within the same patient comparison of 2 thermometry methods: SpotOn skin sensor versus oesophageal temperature probe
|
Active Comparator: Thermometry with oesophageal probe
Nasal insertion of oesophageal temperature probe in the lower fourth of the oesophagus.
|
Within the same patient comparison of 2 thermometry methods: SpotOn skin sensor versus oesophageal temperature probe
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination of accuracy of SpotOn in children
Time Frame: 2 hours
|
degrees centigrade
|
2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hugo Carvalho, MD, Universitair Ziekenhuis Brussel
- Study Chair: Nadia Najafi, MD, Universitair Ziekenhuis Brussel
- Study Director: Jan Poelaert, PhDMD, Universitair Ziekenhuis Brussel
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SpotOn v 1.0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Biomedical Research... and other collaboratorsTerminatedOrphans, Children, Adolescents | Vulnerable Children, Adolescents | Community-basedZimbabwe
-
Duke UniversityBoston Children's Hospital; Agency for Healthcare Research and Quality (AHRQ)Enrolling by invitationChildren, Only | Children and Youth With Special Healthcare NeedsUnited States
-
National Institute of Mental Health (NIMH)RecruitingHealthy Children | Children With Neurodevelopmental Disorders | Children With Neuropsychiatric Disorders | Children With Behavioral SyndromesUnited States
-
Georgetown UniversityPenn State UniversityCompleted
-
Sheffield Children's NHS Foundation TrustUniversity of Sheffield; Sheffield Hallam UniversityCompletedChildrenUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedChildrenUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Burke Medical Research InstituteNot yet recruiting
Clinical Trials on Thermometry
-
University Hospital, BordeauxCompletedProstate Cancer DiagnosisFrance
-
Universidad Peruana Cayetano HerediaJohns Hopkins University; Mayo Clinic; University of Southern CaliforniaCompleted
-
Klinikum NürnbergCompleted
-
Attikon HospitalUniversity Hospital of Patras; Bolton Research FoundationCompletedDiabetic Foot | Peripheral Arterial Disease | Ischaemic NeuropathyGreece, United Kingdom
-
3MCompletedTemperature | Body Temperature | ThermosensingUnited States
-
National Institutes of Health Clinical Center (CC)CompletedLiver Cancer | Hepatic Cancer | Neoplasms, Liver | Hepatic NeoplasmsUnited States
-
University of OxfordOxford University Hospitals NHS Trust; ImunonCompletedLiver TumourUnited Kingdom